| |
| |
|
| Insider
Information: |
Quimi Daphne |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
403,532 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,228,425 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
403,532 |
|
|
| Total
Value |
$4,228,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2023-01-18 |
398,532 |
2014-04-10 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-05-15 |
5,000 |
2024-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-06-15 |
4 |
D |
$11.14 |
$11,652 |
D/D |
(1,046) |
194,179 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
D |
$23.86 |
$99,162 |
D/D |
(4,156) |
244,344 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-31 |
4 |
D |
$23.09 |
$60,496 |
D/D |
(2,620) |
241,724 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-02 |
4 |
D |
$23.09 |
$350,137 |
D/D |
(15,164) |
226,560 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-03 |
4 |
D |
$23.09 |
$116,674 |
D/D |
(5,053) |
221,507 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-01-15 |
4 |
D |
$21.84 |
$104,153 |
D/D |
(4,770) |
259,370 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-03-05 |
4 |
D |
$10.48 |
$48,879 |
D/D |
(4,664) |
271,334 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-31 |
4 |
D |
$11.55 |
$121,298 |
D/D |
(10,502) |
280,127 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-02 |
4 |
D |
$11.55 |
$182,236 |
D/D |
(15,778) |
264,349 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-03 |
4 |
D |
$12.11 |
$18,625 |
D/D |
(1,538) |
262,811 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-04 |
4 |
D |
$12.48 |
$50,432 |
D/D |
(4,041) |
331,906 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-01-14 |
4 |
D |
$10.53 |
$198,417 |
D/D |
(18,843) |
349,903 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-02 |
4 |
D |
$12.21 |
$185,165 |
D/D |
(15,165) |
320,147 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
D |
$11.93 |
$102,300 |
D/D |
(8,575) |
385,080 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
D |
$12.02 |
$355,371 |
D/D |
(29,565) |
410,455 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-07-01 |
4 |
OE |
$13.98 |
$36,350 |
D/D |
2,600 |
10,788 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-10-01 |
4 |
OE |
$13.13 |
$147,761 |
D/D |
11,250 |
16,938 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2016-11-09 |
4 |
OE |
$8.00 |
$22,864 |
D/D |
2,858 |
27,047 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2017-10-12 |
4 |
OE |
$14.25 |
$99,740 |
D/D |
7,000 |
61,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-02 |
4 |
OE |
$14.72 |
$117,723 |
D/D |
8,000 |
62,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-03-01 |
4 |
OE |
$4.16 |
$33,900 |
D/D |
8,149 |
72,481 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-03-09 |
4 |
OE |
$5.96 |
$52,150 |
D/D |
8,750 |
73,082 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-09 |
4 |
OE |
$2.52 |
$30,007 |
D/D |
11,022 |
177,991 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-07-01 |
4 |
OE |
$2.45 |
$52,054 |
D/D |
19,872 |
214,051 |
0 |
- |
|
80 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
